Search
Now showing items 1-4 of 4
Controlled release vaccines and methods of treating Brucella diseases and disorders
(United States. Patent and Trademark Office, 2019-03-05)
Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to ...
2,7-disubstituted cephalosporin derivatives as β-lactamase substrates and methods for their use for the diagnosis of tuberculosis
(United States. Patent and Trademark Office, 2019-07-09)
β-Lactamase substrates and methods for using the substrates to detect β-lactamase and to diagnose tuberculosis.
Controlled release vaccines and methods of treating Brucella diseases and disorders
(United States. Patent and Trademark Office, 2019-03-05)
Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to ...
Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria
(United States. Patent and Trademark Office, 2019-01-08)
The present disclosure provides methods, reagents, systems, and devices that target β lactamase as a biomarker for the sensitive and specific detection of tuberculosis-complex bacteria. Specifically, the present disclosure ...